États-Unis · Bourse & Finance · The Motley Fool

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

Publié par The Motley Fool · États-Unis il y a 13 h

Eli Lilly ( LLY +0.02%) is the only healthcare stock in the trillion-dollar club, and for good reason. Its business has been booming due to its successful GLP-1 drugs, Mounjaro…

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

À lire aussi

A.I. Officials Stonewall on Questions About Technology’s Risks

Solana Debuts Institutional Settlement Standard With J.P. Morgan Input

Trump says MAGA Inc. PAC will pay for controversial TV ads that government funded

Chinese crime network laundered over $1B for Lazarus: ZachXBT

Exclusive: OpenAI is piloting a ‘mission interview’ for job candidates

Elon Musk is a trillionaire again

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

Partager

À lire aussi

A.I. Officials Stonewall on Questions About Technology’s Risks

Solana Debuts Institutional Settlement Standard With J.P. Morgan Input

Trump says MAGA Inc. PAC will pay for controversial TV ads that government funded

Chinese crime network laundered over $1B for Lazarus: ZachXBT

Exclusive: OpenAI is piloting a ‘mission interview’ for job candidates

Elon Musk is a trillionaire again